# Kalderos

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kalderos

- Industry: Software
- Headquarters: Chicago, US
- Website: www.kalderos.com
- Total disclosed funding: $71M
- Latest round: Series B (Dec 23, 2022)
- Investors on record: 5

## About

Based in Illinois, US, and founded in 2016, Kalderos, Inc operates as a technology-based company that offers software solutions for US healthcare systems. The company was founded by its chief strategy officer Jeremy Docken. In June 2020, Kalderos, Inc. raised USD 28 million in series B funding led by Bain Capital Ventures and Mercato Partners.

The firm offers a drug discount management platform that simplifies prescription drug discount compliance. It automates data services, allows access to data and targeted insights, provides custom validation tests, and monitors potential drug discount issues in real time. It offers various services for manufacturers which include MDRP discount monitoring, commercial discount monitoring, and 340B pay. It provides discount hubs as solutions that offer modernization of the inquiry process. The company also offers solutions for state dispute reports.

## Funding rounds

- Series B, Dec 23, 2022, $21M — New Leaf Venture Partners
- Series B, Aug 26, 2022, $15M — Mercato, Alumni Ventures Group, Sepio Capital
- Series B, May 26, 2020, $28M — Bain Capital, Mercato
- Series A, Apr 26, 2019, $7M — Mercato

## Investors

- Mercato (https://capitalatlas.ai/funds/mercato) — Series A, Series B
- Bain Capital (https://capitalatlas.ai/funds/bain-capital) — Series B
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series B
- Sepio Capital (https://capitalatlas.ai/funds/sepio-capital) — Series B
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series B